Ergot alkaloids as lead structures for differential receptor systems
Eich, E.; Pertz, H.
Die Pharmazie 49(12): 867-877
1994
ISSN/ISBN: 0031-7144 PMID: 7838876 Document Number: 426665
Document emailed within 1 workday
Related Documents
Robbers, J.E.; Jones, L.G.; Krupinski, V.M. 1974: Ergot physiology. the production of ergot alkaloids in saprophytic culture by a homokaryotic strain of ergot Lloydia 37(1): 108-111Venn, R.D. 1976: Electroencephalogram and ergot alkaloids Postgraduate Medical Journal 52suppl. 1: 55-56
Walter, U. 1979: Risks of ergot alkaloids in obstetrics Medizinische Monatsschrift für Pharmazeuten 2(3): 76-80
Sterzl, J.; Rehácek, Z.; Cudlín, J. 1987: Regulation of the immune response by ergot alkaloids Czechoslovak Medicine 10(2): 90-98
Midgley, L.P.; Bush, L.G.; Gibb, J.W.; Hanson, G.R. 1993: Differential regulation of neuropeptide Y systems in limbic structures of the rat Journal of Pharmacology and Experimental Therapeutics 267(2): 707-713
Schran, H.F.; Schwarz, H.J.; Talbot, K.C.; Loeffler, L.J. 1979: Specific radioimmunoassay of ergot peptide alkaloids in plasma Clinical Chemistry 25(11): 1928-1933
Gorini, A.; Arnaboldi, R.; Vercesi, L.; Dossena, M. 1988: Influence of some ergot alkaloids on the cerebral reduced glutathione Il Farmaco; Edizione Scientifica 43(11): 887-890
Bernardi, L. 1979: From ergot alkaloids to nicergoline/Chemical points of view Arzneimittel-Forschung 29(8a): 1204-1206
Mercier, C. 1982: Peptide alkaloids of spurred rye and their semisynthetic derivatives. III. Ergot in therapeutics Journal de Pharmacie de Belgique 37(4): 289-298
Schmitt, H.; Fenard, S. 1970: Effects of ergot alkaloids on the vasomotor centers and their inhibition by clonidine Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(5): 1006-1009
Floss, H.G.; Basmadjian, G.P.; Tcheng, M.; Gröger, D.; Erge, D. 1971: Biosynthesis of peptide-type ergot alkaloids. Ergocornine and ergocryptine Lloydia 34(4): 446-448
Vaupel, P.; Hutten, H. 1980: Acute changes in intracerebral vascular resistance after application of dihydrogenated ergot alkaloids Arzneimittel-Forschung 30(4): 598-602
Gröger, D.; Syring, U.; Johne, S. 1975: Syntheses of radioactive cyclols as potential precursors of the peptide moiety of ergot alkaloids Die Pharmazie 30(7): 440-443
Kozlovskiĭ, A.G.; Zhelifonova, V.P.; Antipova, T.V.; Zelenkova, N.F. 2011: Physiological and biochemical characteristics of fungi of the genus Penicillium as producers of ergot alkaloids and quinocitrinins Prikladnaia Biokhimiia i Mikrobiologiia 47(4): 469-473
Loew, D.M.; Depoortere, H.; Buerki, H.R. 1976: Effects of dihydrogenated ergot alkaloids on the sleep-wakefulness cycle and on brain biogenic amines in the rat Arzneimittel-Forschung 26(6): 1080-1083
Sarsúnová, M.; Semonský, M.; Cerný, A. 1970: Ergot alkaloids. XXXVI. Separation of diastereomeric (+)-1-hydroxy-2-butylamides of D- and L-lysergic and D- and L-isolysergic acids by thin-layer chromatography Journal of Chromatography 50(3): 442-446
Miragoli, G.; Ferrini, R. 1974: Effect of the combination of raubasine and hydrogenated ergot alkaloids on the isolated and perfused rat caudal artery and rabbit internal carotid artery Bollettino della Societa Italiana di Biologia Sperimentale 50(19): 1622-1628
Maruna, R.F.; Maruna, H.; Altmann, P.; Georgiades, E.; Michalica, W. 1975: Lead content of the placenta and urinary excretion of delta aminolevulinic acid in the mother and newborn infant as a graduator of the differential exposure to lead. (4. Report on the lead load of different occupational and population groups of the Vienna area) Wiener Medizinische Wochenschrift 125(47): 678-681
Huang, W. 1998: A suggestion for unification of present limb lead systems into a single "F" lead system Chinese Medical Journal 111(6): 565-569
Leng, S.; Song, W.; Gu, Y.; Wang, Y. 2003: Associations of Bsm1 polymorphism of the vitamin D receptor gene and blood lead, zinc protoporphyrin, and physical development in 476 environmental lead-exposed children Wei Sheng Yan Jiu 32(6): 610-612